Cargando…
Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots - performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification
BACKGROUND: Nowadays, dried blood spots (DBS) are primarily used to obtain diagnostic access to risk collectives such as intravenous drug users, who are prone to infections with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). Before DBS analyses can be used...
Autores principales: | Ross, R Stefan, Stambouli, Oumaima, Grüner, Nico, Marcus, Ulrich, Cai, Wei, Zhang, Weidong, Zimmermann, Ruth, Roggendorf, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599381/ https://www.ncbi.nlm.nih.gov/pubmed/23497102 http://dx.doi.org/10.1186/1743-422X-10-72 |
Ejemplares similares
-
Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
por: Grüner, Nico, et al.
Publicado: (2015) -
Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life
por: Mössner, Belinda K, et al.
Publicado: (2016) -
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
por: Shyamala, Venkatakrishna
Publicado: (2014) -
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
por: Kumar, Rajesh, et al.
Publicado: (2015) -
Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting
por: Vázquez-Morón, Sonia, et al.
Publicado: (2018)